Yotam Elimeleh

1PUBLICATIONS
0CO-AUTHORS
Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 21, 2025
Safety and efficacy of adalimumab 40 mg every 3 weeks in pediatric-onset Crohn's disease.

Yotam Elimeleh, Anat Y Feler, Rula T Badarni

Pageof 1

Frequent Collaborators